Medtronic, Inc. today began the international launch of the Driver Sprint RX Coronary Stent System, which received the CE Mark in February 2009 and is planned to be commercially available in more than 100 countries worldwide.
Specialty
U.S. advisers reject wider Stryker bone putty use
Stryker Corp’s bone-growth putty for spinal surgery should not be approved for expanded use in a wider population, advisors to federal drug regulators said on Tuesday.
Gore Receives FDA Approval For Larger Diameter, Small Profile AAA Endoprosthesis
W. L. Gore & Associates announced that it has received approval from the US Food and Drug Administration to market a 31 mm diameter version of the GORE EXCLUDER® AAA Endoprosthesis.
Trial Shows Important Clinical Benefit Of MitraClip® Therapy In High Risk Patients
Percutaneous mitral valve repair using the MitraClip® system in high-risk surgical patients with improves patient clinical status according to data from the registry arm of the EVEREST II study.
Thrombus Aspiration With Medtronic’s Export Catheter May Improve Outcomes For Heart Attack Patients
Removing thrombus from coronary arteries with the Export Aspiration Catheter from Medtronic, Inc., before implanting a stent in patients suffering a specific kind of heart attack, “results in excellent clinical outcomes,” at one year, according to new data released today at the American College of Cardiology meeting.
Medtronic’s Endeavor Stent Shows Consistent And Sustained Safety And Effectiveness Benefits At Two Years
New data released at the 2009 American College of Cardiology meeting demonstrated exceptional long-term safety and effectiveness results for the Endeavor drug-eluting coronary stent from Medtronic, Inc.
Multiple Uses For Ground Breaking Ice Pack
A ground breaking ice pack, which has benefits for both osteoarthritis patients and athletes, has been launched by North Yorkshire healthcare innovations company, Salitas.
St. Jude Medical and GE Healthcare Announce Worldwide Market Launch of Wireless Integrated FFR Solution
St. Jude Medical, Inc. and GE Healthcare today announced the worldwide commercial launch of the first fully integrated wireless solution for the measurement of Fractional Flow Reserve (FFR).
MEDIHONEY™ Dressings Shown to Improve Outcomes of Non-Healing Venous Leg Ulcers
Derma Sciences, Inc., a provider of advanced wound care products, announced today that its MEDIHONEY Dressings were the focus of a case series on eleven non-healing venous leg ulcers.
Cordis Celebrates 50 Years of Transforming Cardiovascular Care
Cordis Corporation, a leading developer and manufacturer of breakthrough treatments for cardiovascular disease, is celebrating its 50th anniversary this month.
SenoRx Announces CE Mark to Commercialise Contura™ MLB in Europe
SenoRx today announced that it has received the right to apply the CE Mark to its Contura(tm) MLB short-term breast radiation balloon catheter.
Hip Resurfacing Championed as a Bone-Preserving Alternative to Total Hip Replacement
According to Millennium Research Group’s US Markets for Large-Joint Reconstructive Implants 2009 report, hip resurfacing will be the fastest-growing segment of the large-joint reconstructive implant market through 2013, rising at a compound annual growth rate of over 25%.
OrSense Receives European CE Mark Approval For New Monitoring System
OrSense Ltd. announced today that it has received a European CE Mark approval for its NBM-200MP, a Continuous Non-Invasive Hemoglobin And Pulse Oximetry Monitoring System.
Covidien Receives FDA Clearance For New Pulse Oximeter With OxiMax SPD™ Alert
Covidien announced today that the United States Food and Drug Administration has issued a 510(k)marketing clearance for the Nellcor™ OxiMax™ N-600x™ pulse oximeter with OxiMax SPD™ alert.
Physical Activity Monitor Revolutionises Hip And Knee Surgery
A revolutionary new physical activity monitoring system which compares actual patient activity with researched norms for individual patient types has been unveiled to support orthopaedic surgeons and GPs in their decision making processes along the care pathway.
NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received CE Mark for the cPAX Aneurysm Treatment System.